ERBB2 and breast cancer: This accounts for TNBC being unresponsive to hormone therapy and HER2-targeted therapies.22 Approximately 75% of the breast cancers associated with BRCA1 mutations are TNBCs.23 Obesity is more frequently associated with TNBC than with other breast cancer subtypes.